Caladrius biosciences inc

Hospital/Nursing-Management

CLBS


Executive/
Director

Links

Price

  • Last Close
  • $ 4.77
    $ +0.08 1.71 %
    Sep 20, 2022
  • 52-Week High/Low
  • $0 - $0
  • YTD
  • 0%

  • Trading Volume
  • 99,277
  • Market Cap Full
  • $ 38.8M
  • Shares Outstanding
  • 8.1M
    Nov 2, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - -30.6% 77.7% 66.4% 1.7% -5% 32.2% -16.1% - -
Q2 -19.7% -21.3% -7.6% 19.4% -35.5% 4% -14.8% -26.6% - -
Q3 -20.3% -21.4% -23% -8.2% 2.6% 8% -24.2% 800% - -
Q4 -27.5% -39% -3.8% -38.3% 5.8% -20.6% -29.5% - - -
J F M A M J J A S O N D
2024 - - - - - - - - - - - -
2023 - - - - - - - - - - - -
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%-74%24%1%-28%-44%-40%455%0%0%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022
Q1 - 0.21 1.12 -0.52 -0.44 -0.38 -0.19 -
Q2 0.31 1.33 0.88 -0.42 -0.49 0.5 -0.1 -
Q3 0.21 1.09 0.38 -0.36 -0.47 -0.29 -0.12 -
Q4 0.15 0.73 0.40 -0.37 -0.48 -0.36 - -
A 0.7 3.4 2.8 -1.7 -1.9 -0.5 -7.5 -10.5

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 10 10.6 59.5 60.5 8
Jun 9.6 10.4 12.8 59.5 60.5 8
Sep 9.7 10.4 19.3 59.5 60.6 8.1
Dec 9.8 10.4 19.4 59.8 7.9 8.1

Financial Ratios

20202019201820172016
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - 0.1
Debt – Equity Ratio - - - - 0.7
Interest Coverage 1.7 27.5 20.7 0.6 -9.4
Equity multiplier - 0.1 - - 7.1